Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. infection protection
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Date

  • Older

Infection Protection Articles & Analysis: Older

15 articles found

TOMI SteraMist Helps Controlling the Spread of C. auris

TOMI SteraMist Helps Controlling the Spread of C. auris

The CDC has cited poor general infection protection and control (IPC) practices in healthcare facilities as one of the many reasons for the increased occurrence of C. auris cases and in which outbreaks occur. ...

BySteraMist Disinfection


Schistosome Vaccine, Schistoshield - Case Study

Schistosome Vaccine, Schistoshield - Case Study

Currently an estimated 200 million are infected and an additional an estimated 800 million people are at risk of acquiring this disease in 74 countries. ...

ByPAI Life Sciences


FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years

FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years

This study is the first of its kind to evaluate M2SR in children under 9 years old, a population with the greatest rates of flu infection each year and who are at higher risk of serious complications or death. ...

ByFluGen, Inc.


FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults

” The synergistic effects of combining intranasally delivered M2SR with intramuscularly delivered high dose IIV is a novel approach that could significantly boost the effectiveness of flu vaccines and protect from the drifting of flu strains from year to year. The study will evaluate subjects’ ability to raise mucosal antibodies in the nasal passages, serum ...

ByFluGen, Inc.


Vitamins: Types and Their Functions

Vitamins: Types and Their Functions

Vitamin A: Helps body growth and tissue repair, helps with eye health, fights bacteria to avoid infection, protects epithelial tissue health, and promotes bone and tooth development. ...

ByCreative Proteomics


Cyber security challenges in hospitals

Cyber security challenges in hospitals

Good reading! ‍The main risks of viral infection Our machine is designed for the operating theater, which means that it must work in all circumstances: it must therefore be protected against the risk of viral infection. ...

ByISIS S.A.S


FluGen Announces Publication of Positive Results from Phase 2 Human Challenge Study of Its M2SR Vaccine Candidate Against Highly Drifted Strain of H3N2 Influenza Virus

FluGen Announces Publication of Positive Results from Phase 2 Human Challenge Study of Its M2SR Vaccine Candidate Against Highly Drifted Strain of H3N2 Influenza Virus

Results published in the Journal of Infectious Diseases show that subjects with vaccine-induced neutralizing antibodies were protected against infection and illness following challenge with an antigenically distinct virus. ...

ByFluGen, Inc.


FluGen Awarded US Department of Defense Funding to Conduct Clinical Study Evaluating Investigational M2SR Flu Vaccine and Current Standard-of-Care High Dose Vaccine

FluGen Awarded US Department of Defense Funding to Conduct Clinical Study Evaluating Investigational M2SR Flu Vaccine and Current Standard-of-Care High Dose Vaccine

“FluGen is committed to ensuring older adults are protected from the flu virus, and particularly drifted strains, and the current standard of care has not been shown to be widely effective in protecting this population from virus drift, particularly against H3N2. ...

ByFluGen, Inc.


FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

Exposure to circulating virus that has drifted from the vaccine virus further compounds the burden of flu and makes protecting people in this age group by vaccination even more critical,” said Dr. ...

ByFluGen, Inc.


Trimmed for health from the roof to the basement – Germany’s first office Low-Infection Building® with UVENTIONS

Trimmed for health from the roof to the basement – Germany’s first office Low-Infection Building® with UVENTIONS

The Pforzheim-based company Pfirmann Industriebau is now planning a “low-infection Building®”, which could be a blueprint for equipping new buildings in terms of infection protection. The multi-storey office building with more than 2,000 m² of floor space should be able to protect employees more efficiently ...

ByUVENTIONS


COVID-19: We all have skin in the game

COVID-19: We all have skin in the game

Blueberry Therapeutics is a drug development company committed to finding new and improved treatments for a range of dermatological conditions affecting the skin and nails. The future and long-term effect of the global COVID-19 pandemic (caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2 virus]) on dermatology practice and skin health is still unknown, but here we provide some ...

ByBlueberry Therapeutics


Hospitals and Surgery Suits

Hospitals and Surgery Suits

Promote the reduction in some disease, like allergies, respiratory disease, nasal congestions, skin infections. Protect building spaces from mold, mildew and ...

ByHangzhou Greeme Environmental Technology Co., Ltd.


Hospitals and Surgery Suits

Hospitals and Surgery Suits

Promote the reduction in some disease, like allergies, respiratory disease, nasal congestions, skin infections. Protect building spaces from mold, mildew and ...

ByHangzhou Greeme Environmental Technology Co., Ltd.


Hospitals and Surgery Suits

Hospitals and Surgery Suits

Promote the reduction in some disease, like allergies, respiratory disease, nasal congestions, skin infections. Protect building spaces from mold, mildew and ...

ByHangzhou Greeme Environmental Technology Co., Ltd.


Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection

Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection

The cornea is essential for vision yet highly sensitive to immune-mediated damage following infection. Generating vaccines that provide sterile immunity against ocular surface pathogens without evoking vision loss is therefore clinically challenging. ...

ByRational Vaccines, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT